Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nedaplatin versus cisplatin concurrent with IMRT after radical surgery for stage I-IIA cervical cancer
ChiCTR1800020280Phase 3Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Feb 2019
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Cervical Cancer (CC) comparing Nedaplatin + IMRT with Cisplatin + IMRT (2 arms). Primary endpoint: Progression-free survival. Started Feb 2019; status: recruiting.
02
Drugs
nedaplatincisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR1800020280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020280.